United Kingdom· GB-APID-39235811000001109
Vitrakvi 100mg capsules
A larotrectinib product containing larotrectinib, registered in United Kingdom by Bayer Plc. The same ATC class is registered in 13 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Larotrectinib is registered in 13 of 19 countries.
Countries holding a registration under ATC L01EX12 (larotrectinib), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 8 of them publish a price we can compare per daily dose
Larotrectinib · ATC L01EX12
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of larotrectinib costs, country by country.
Normalised to the WHO defined daily dose (0.2 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Larotrectinib · price per daily dose (0.2 g)
USD · FX 28 Sept 2026
- CH Switzerland$254.41
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Larotrectinib
- Manufacturer
- Bayer Plc
- Country
- United Kingdom (GB)
- ATC code
- L01EX12
- ATC class
- Larotrectinib
- Defined daily dose
- 0.2 g, O
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 2
- gtin4057598009928
- gtin04057598027595
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
527 interactions on record for larotrectinib.
Graded by severity as the source publishes them — 55 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Larotrectinib · interactions on record
527 records
- 55 severe
- 456 moderate
- 16 minor
Most severe, free to view
- LonafarnibA16AX20severe
- ConivaptanC03XA02severe
- MipomersenC10AX11severe
- LomitapideC10AX12severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Larotrectinib in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandVITRAKVIBayer AG
- United StatesVITRAKVILoxo Oncology, Inc.
- SwitzerlandVitrakvi 100 mg, KapselnBayer (Schweiz) AG
- CzechiaVITRAKVIBayer AG, Leverkusen
- SpainVITRAKVI 100 MG CAPSULAS DURASBayer Ag
- BelgiumVitrakvi 100 mgBayer
- IcelandVITRAKVIBayer AG
- NetherlandsVitrakvi 100 mg, harde capsulesBayer AG
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Vitrakvi
- Liechtenstein · Vitrakvi
- Norway · Vitrakvi
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/20a76868-cf4d-497f-b67f-01977ac97afe GET /v1/drugs/20a76868-cf4d-497f-b67f-01977ac97afe?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "39235811000001109",
"desc": "Vitrakvi 100mg capsules (Bayer Plc)",
"form": "Oral capsule",
"vpid": "39389711000001100",
"source": "dmd",
"vtm_id": "782992002",
"strength": "100 mg",
"substance": "Larotrectinib",
"ingredient": "Larotrectinib sulfate",
"supplier_code": "2063701000001109"
}See everything about larotrectinib.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.